Company Intelligence

Tempus AI

Tempus AI provides enterprise-grade artificial intelligence solutions, delivering specialized Tempus AI Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.

Headquarters
Chicago, United States
Founded
2015
Status
Active
Products
1
Reports
8
Last reviewed
Aug 2026

Overview

What this company is, what it builds, and who it serves.

Tempus AI is a Healthcare AI company based in Chicago, United States, founded in 2015.

Chicago-based precision medicine company applying AI and multimodal data to oncology and clinical decision support.

Verified founder profile on Brel: Eric Lefkofsky.

What it builds

Tempus AI Platform

Why It Matters

Tempus AI provides enterprise-grade artificial intelligence solutions, delivering specialized Tempus AI Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.

Products

Products and platforms connected to this company.

Founders

People linked to this company in the Brel founder graph.

Ecosystem

How this company connects across the Brel AI intelligence graph.

Company

Tempus AI

Industry

Industries served

  • Healthcare Technology

Capabilities

Tempus applies machine learning and AI across structured clinical and molecular datasets to surface patterns that would be difficult for manual review…

Features

  • Precision medicine platform combining clinical and molecular data, AI analytics, and decision-support tools for oncology
  • clinical
  • molecular data
  • AI analytics
  • decision-support tools for oncology
  • broader therapeutic areas
  • used by health systems
  • researchers

Country

United States

Official Resources

Official and developer links on file for this company.

Latest Developments

Verified developments and timeline notes on file.

  • March 3, 2026: Tempus announced a multi-year strategic collaboration agreement with Merck to accelerate AI-driven precision medicine through Tempus Lens and related capabilities. Latest
  • Company founded 2015 · founded Source
  • Development 2015 · development Source
  • Acquisition 2025 · acquisition Source

Partnerships

  • March 3, 2026: Tempus announced a multi-year strategic collaboration agreement with Merck to accelerate AI-driven precision medicine through Tempus Lens and related capabilities.

Frequently Asked Questions

What does Tempus AI do?

Tempus AI specializes in artificial intelligence, developing Tempus AI Platform to support enterprise software developers and digital transformation teams with scalable, production-grade technology.

Where is Tempus AI based and when was it founded?

Tempus AI is based in United States and was founded in 2015.

What are the main products offered by Tempus AI?

The flagship platform from Tempus AI is Tempus AI Platform, delivered primarily through b2b saas and enterprise api licensing.

Who are the primary target users of Tempus AI?

Tempus AI primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.

Sources & Verification

How this profile is verified and where the information comes from.

Verified
Last reviewed Aug 2026

Primary sources

Request a correction if you represent this company or believe information is inaccurate.